Cabot Corporation (CBT) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$78.93
Price Target
$78.00
Target Range
$74.00 — $85.00
Analyst Rating
Buy
Forward P/E12.7x
Trailing P/E13.1x
Forward PEG—
Implied Growth+6.0%
Median Target$75.00
Analyst Spread14.1%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$74
-6.2%
Consensus
$78
-1.2%
Bull Case
$85
+7.7%
Valuation Model TargetsConfidence: 57/100
Bear$10
Base$80
Bull$149
CBT Price Target Analysis
Updated May 6, 2026As of May 6, 2026, Cabot Corporation (CBT) has a Wall Street consensus price target of $78.00, based on estimates from 15 covering analysts. With the stock currently trading at $78.93, this represents a potential downside of -1.2%. The company has a market capitalization of $4.12B.
Analyst price targets range from a low of $74.00 to a high of $85.00, representing a 14% spread in expectations. The median target of $75.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 7 analysts rating the stock as a Buy or Strong Buy,7 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, CBT trades at a trailing P/E of 13.1x and forward P/E of 12.7x. Analysts expect EPS to grow +6.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $79.64, with bear and bull scenarios of $9.91 and $148.77 respectively. Model confidence stands at 57/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Basic Materials stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside-5.2%
Avg Forward P/E20.6x
Peers with Coverage9 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 KROKronos Worldwide, Inc. | $897M | $7.80 | $5.00 | -35.9% | Hold | — | 7 |
 IOSPInnospec Inc. | $1.9B | $78.20 | $115.00 | +47.1% | Hold | 15.8x | 9 |
 HWKNHawkins, Inc. | $3.5B | $167.00 | — | — | Buy | 42.3x | 1 |
 TROXTronox Holdings plc | $1.7B | $10.48 | $7.25 | -30.8% | Buy | — | 17 |
 ASIXAdvanSix Inc. | $868M | $26.17 | $22.00 | -15.9% | Buy | 17.2x | 6 |
 ECVTEcovyst Inc. | $1.6B | $14.73 | $9.67 | -34.4% | Buy | 24.1x | 6 |
 PPGPPG Industries, Inc. | $23.8B | $106.41 | $127.67 | +20.0% | Buy | 13.5x | 38 |
 EMNEastman Chemical Company | $8.8B | $77.29 | $77.29 | +0.0% | Buy | 13.1x | 35 |
 HUNHuntsman Corporation | $2.6B | $14.99 | $12.00 | -19.9% | Hold | — | 33 |
 RPMRPM International Inc. | $12.7B | $99.41 | $122.67 | +23.4% | Buy | 18.1x | 22 |
Upside Potential Comparison
IOSPRPMPPGEMNASIXHUNTROXECVTSee CBT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CBT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CBT vs LIN
Side-by-side business, growth, and profitability comparison vs Linde plc.
Start ComparisonCBT — Frequently Asked Questions
Quick answers to the most common questions about buying CBT stock.
What is the CBT stock price target for 2026?
Wall Street's consensus price target for CBT is $78, -1.2% from its current price of $78.93. The below-market target from 15 analysts suggests limited near-term appreciation.
Is CBT a buy, sell, or hold?
CBT has a consensus rating of "Buy" based on 15 Wall Street analysts. The rating breakdown is mixed, with 7 Hold ratings making up the largest segment. The consensus 12-month price target of $78 implies -1.2% downside from current levels.
Is CBT stock overvalued or undervalued?
With a forward P/E of 12.6671x, CBT trades at a relatively low valuation. The consensus target of $78 implies -1.2% move, suggesting the market may be pricing in risks.
How high can CBT stock go?
The most bullish Wall Street analyst has a price target of $85 for CBT, while the most conservative target is $74. The consensus of $78 represents the median expectation. Our quantitative valuation model projects a bull case target of $149 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover CBT stock?
CBT is well covered by analysts, with 15 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 7 have Buy ratings, 7 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the CBT stock forecast?
The 12-month CBT stock forecast based on 15 Wall Street analysts shows a consensus price target of $78, with estimates ranging from $74 (bear case) to $85 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $80, with bear/bull scenarios of $10/$149.
What is CBT's fair value based on fundamentals?
Our quantitative valuation model calculates CBT's fair value at $80 (base case), with a bear case of $10 and bull case of $149. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 57/100.
What is CBT's forward P/E ratio?
CBT trades at a forward P/E ratio of 12.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 13.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy CBT stock?
Analysts are cautious on CBT, with 1 Sell ratings and a price target of $78 (-1.2% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do CBT price targets vary so much?
CBT analyst price targets range from $74 to $85, a 14% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $78 consensus represents the middle ground. Our model's $10-$149 range provides an independent fundamental perspective.